2024 Session

Budget Amendments - HB30 (Conference Report)

Prescription Drug Affordability Board

Item 283.10 #1c

Item 283.10 #1c

First Year - FY2025 Second Year - FY2026
Health and Human Resources
Department of Health FY2025 $303,650 FY2026 $648,000 GF
FY2025 3.00 FY2026 3.00 FTE

Page 317, after line 5, insert:

"283.10 Establish Prescription Drug Affordability Board$303,650$648,000
Fund Sources:  General $303,650 $648,000 "


(This amendment provides $303,650 the first year and $648,000 the second year from the general fund and three positions for the fiscal impact of legislation passed during the 2024 Regular Session, which establishes the Prescription Drug Affordability Board for the purpose of identifying high cost prescription drugs, reviewing pricing and cost information, conducting affordability reviews of selected prescription drug products, and if necessary, setting an upper payment limit, which shall apply to all purchases and payer reimbursements for the product dispensed in the Commonwealth.)